Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon M Cool

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Biomaterials|August 7, 2010
Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffoldsBina Rai, Jane L Lin, Zophia X H Lim, et al.
Arthritis Research & Therapy|August 7, 2024
Retraction Note: Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytesDongyao Yan, Di Chen, Simon M Cool, et al.
Arthritis Research & Therapy|August 13, 2011
Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytesDongyao Yan, Di Chen, Simon M Cool, et al.
Molecular Cancer|July 24, 2015
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapyLing Ling, Si Kee Tan, Ting Hwee Goh, et al.
Journal of Cellular Physiology|May 28, 2010
FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signalingVanessa M Y Ding, Ling Ling, Subaashini Natarajan, et al.
Stem Cells Translational Medicine|February 17, 2017
Microfluidic Screening Reveals Heparan Sulfate Enhances Human Mesenchymal Stem Cell Growth by Modulating Fibroblast Growth Factor-2 TransportDrew M Titmarsh, Clarissa L L Tan, Nick R Glass, et al.
Journal of Cellular Biochemistry|December 21, 2013
Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicityRachel K Okolicsanyi, Andre J van Wijnen, Simon M Cool, et al.
Tissue Engineering. Part A|December 1, 2016
Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering ApplicationsBethanie I Ayerst, Raymond A A Smith, Victor Nurcombe, et al.
Journal of Molecular Histology|September 13, 2007
Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial modelMaria Ann Woodruff, Subha Narayan Rath, Evelyn Susanto, et al.
Tissue Engineering. Part A|November 25, 2020
Combination of BMP2 and EZH2 Inhibition to Stimulate Osteogenesis in a 3D Bone Reconstruction ModelHayman Lui, Rebekah M Samsonraj, Cedryck Vaquette, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Biomaterials|August 7, 2010
Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffoldsBina Rai, Jane L Lin, Zophia X H Lim, et al.
Arthritis Research & Therapy|August 7, 2024
Retraction Note: Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytesDongyao Yan, Di Chen, Simon M Cool, et al.
Arthritis Research & Therapy|August 13, 2011
Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytesDongyao Yan, Di Chen, Simon M Cool, et al.
Molecular Cancer|July 24, 2015
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapyLing Ling, Si Kee Tan, Ting Hwee Goh, et al.
Journal of Cellular Physiology|May 28, 2010
FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signalingVanessa M Y Ding, Ling Ling, Subaashini Natarajan, et al.
Stem Cells Translational Medicine|February 17, 2017
Microfluidic Screening Reveals Heparan Sulfate Enhances Human Mesenchymal Stem Cell Growth by Modulating Fibroblast Growth Factor-2 TransportDrew M Titmarsh, Clarissa L L Tan, Nick R Glass, et al.
Journal of Cellular Biochemistry|December 21, 2013
Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicityRachel K Okolicsanyi, Andre J van Wijnen, Simon M Cool, et al.
Tissue Engineering. Part A|December 1, 2016
Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering ApplicationsBethanie I Ayerst, Raymond A A Smith, Victor Nurcombe, et al.
Journal of Molecular Histology|September 13, 2007
Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial modelMaria Ann Woodruff, Subha Narayan Rath, Evelyn Susanto, et al.
Tissue Engineering. Part A|November 25, 2020
Combination of BMP2 and EZH2 Inhibition to Stimulate Osteogenesis in a 3D Bone Reconstruction ModelHayman Lui, Rebekah M Samsonraj, Cedryck Vaquette, et al.
Pageof 13